SoFi, Affirm and William Blair
Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...
William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...
William Blair boosted their FY2024 earnings per share estimates for Certara in a research note issued on Wednesday, January 15th. William Blair analyst M. Smock now expects that the company will earn ...
William Blair International Growth Fund earns an Average Process Pillar rating. The most important driver of the rating is the stability of the management team. Specifically, the fund has not seen ...
William Blair has initiated coverage on Denali Therapeutics Inc (NASDAQ:DNLI), a company focused on developing drugs for ...
CHICAGO, January 07, 2025--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named Stewart ...
William Blair Global Leaders Fund earns a Below Average Process Pillar rating. The process is bolstered by low costs across its parent firm's funds, whose fees rank in their respective category's ...
Fintel reports that on January 14, 2025, William Blair upgraded their outlook for CVRx (NasdaqGS:CVRX) from Market Perform to Outperform. As of December 23, 2024, the average one-year price target ...
Research analysts at William Blair dropped their FY2025 earnings estimates for shares of OneSpaWorld in a research report issued on Monday, January 13th. William Blair analyst S. Zackfia now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback